This Experimental Drug Could Be a Game Changer for Pancreatic Cancer

Gizmodo — Apr 14, 16:45 PM

In a Phase III trial, Revolution Medicines' daraxonrasib almost doubled the survival length of people with advanced pancreatic cancer.

Read full article at Gizmodo →

Pancreatic Cancer Breakthrough

Pancreatic cancer pill shown to nearly double overall survival time, drug company says The Hill — Apr 14, 11:53 AM
Pancreatic cancer breakthrough as scientists develop new drug that 'doubles survival rate' of silent killer Daily Mail — Apr 14, 10:26 AM
Two New Drugs Offer Hope for Pancreatic Cancer Time — Apr 14, 16:23 PM